Emilio J. Barcelo-Sanchez
Santander, CB 39011, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Melatonin: A Molecule for Reducing Breast Cancer Risk.
Journal: Molecules (Basel, Switzerland)
Published: January 09, 2018
Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders.
Journal: Current medicinal chemistry
Published: April 03, 2017
Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome.
Journal: Behavioural brain research
Published: March 11, 2017
Chronic Melatonin Administration Reduced Oxidative Damage and Cellular Senescence in the Hippocampus of a Mouse Model of Down Syndrome.
Journal: Neurochemical research
Published: May 30, 2016
Constitutive photomorphogenesis protein 1 (COP1) and COP9 signalosome, evolutionarily conserved photomorphogenic proteins as possible targets of melatonin.
Journal: Journal of pineal research
Published: April 05, 2016
Recent patents on light based therapies: photodynamic therapy, photothermal therapy and photoimmunotherapy.
Journal: Recent patents on endocrine, metabolic & immune drug discovery
Published: September 12, 2013
Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome.
Journal: Journal of pineal research
Published: August 12, 2013
The effect of estradiol, progesterone, and melatonin on estrous cycling and ovarian aromatase expression in intact female mice.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: June 26, 2013
Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome.
Journal: Journal of pineal research
Published: August 15, 2012
Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation.
Journal: Expert opinion on investigational drugs
Published: April 17, 2012
Breast cancer therapy based on melatonin.
Journal: Recent patents on endocrine, metabolic & immune drug discovery
Published: December 30, 2011
Clinical uses of melatonin: evaluation of human trials.
Journal: Current medicinal chemistry
Published: January 17, 2010
Last Updated: 09/26/2026